Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Stipan Jonjic, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry